The use of dual antiplatelet therapy (DAPT), either with clopidogrel or ticagrelor (Brilinta; AstraZeneca), appears to reduce the risk of failing saphenous vein grafts among patients who undergo CABG ...
LONDON, England—The “no-touch” harvesting technique for patients undergoing CABG surgery using a saphenous vein graft does not lower the risk of graft failure but is associated with a significantly ...
LAS VEGAS, Nov. 2, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine through education and research, today announced results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results